Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

» Details

Guru Trades

VHT Guru Trades in

VHT Guru Trades in

Q4 2015

VHT Guru Trades in Q4 2015

Ken Fisher 1,808 sh (New)
» More
Q1 2016

VHT Guru Trades in Q1 2016

Ken Fisher Sold Out
» More

Ratios

vs
industry
vs
history
P/E(ttm) 23.61
VHT's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 23.61 )
Ranked among companies with meaningful P/E(ttm) only.
VHT' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.12
Current: 23.61
0
24.12
PE(NRI) 23.61
VHT's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 23.61 )
Ranked among companies with meaningful PE(NRI) only.
VHT' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 24.12
Current: 23.61
0
24.12
P/B 3.76
VHT's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 3.76 )
Ranked among companies with meaningful P/B only.
VHT' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 3.86
Current: 3.76
0
3.86

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.82
VHT's Dividend Yield is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 1.82 )
Ranked among companies with meaningful Dividend Yield only.
VHT' s Dividend Yield Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.8
Current: 1.82
0
1.8
Yield on cost (5-Year) 1.79
VHT's Yield on cost (5-Year) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VHT: 1.79 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
VHT' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.8
Current: 1.79
0
1.8

More Statistics

Short Percentage of Float0.00%
52-Week Range $114.49 - 138.38
Shares Outstanding (Mil)42,831,212.00
» More Articles for VHT

Headlines

Articles On GuruFocus.com
Mawer New Canada Buys Domestic Aug 24 2016 
Merck Offers Value and Steady Dividend Growth Aug 24 2016 
Why Jeffrey Ubben of ValueAct Capital Is Big on Morgan Stanley Aug 24 2016 
Eldorado Gold Corp Announces New Projects Aug 24 2016 
5 Stages of a Sovereign's Life Cycle Aug 24 2016 
How Would Hillary Clinton’s Proposals Affect Investors? Aug 24 2016 
Adam Smith's 'The Money Game' Aug 24 2016 
1 Big Thing Build-A-Bear Workshop CEO Wants You to Know Aug 24 2016 
The Current Status of Tourism Stocks Aug 24 2016 
Home Depot: An Excellent Stalwart Aug 24 2016 

More From Other Websites
An Appealing, Cost-Efficient Healthcare ETF Aug 23 2016
ETFs in Focus on Pfizer's Medivation Acquisition Aug 22 2016
What Do Analysts Estimate for Merck? Aug 17 2016
Analyzing the Future Estimates for Pfizer Aug 16 2016
Is Merck’s Valuation Improving? Aug 12 2016
Major Product Developments for Pfizer Aug 12 2016
The Vanguard Effect: Lower Expenses, Higher Returns Aug 10 2016
Pfizer’s Business Segments and Their Performance Aug 10 2016
Analyzing Future Estimates for Eli Lilly Aug 08 2016
Major Developments for Eli Lilly in 2Q16 Aug 05 2016
Sector ETF Positioning for the Rest of the Year Aug 04 2016
Take Profits in PetMed, Then Wait for a Pullback Jul 26 2016
3 Healthcare ETFs to Buy as JNJ Beats Q2 Earnings Jul 21 2016
UnitedHealth's Chart Shows Healthy Stock Run Ahead Jul 18 2016
Stick With Johnson & Johnson for Healthy Gains Jul 18 2016
Pfizer’s Recent Corporate and Pipeline Developments Jul 08 2016
What Are Pfizer’s Major Product Developments? Jul 08 2016
Q2 Earnings to Gather Steam: 4 Sector ETFs & Stocks to Play Jul 08 2016
Understanding Pfizer’s Growth Contributors Jul 01 2016
How Are Pfizer’s Business Segments Performing? Jul 01 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK